Company intelligence / Profile preview

Biofrontera Discovery

Leipzig, Saxony, Germany

Ownership: Private
Development stage: Other

Overview

Biofrontera Discovery was a subsidiary of Biofrontera AG focused on the early-stage research and discovery of novel small molecule therapeutics. Based in Leipzig, Germany, the unit specialized in identifying new active pharmaceutical ingredients for the treatment of inflammatory and dermatological diseases. The company utilized proprietary screening technologies and chemical libraries to fuel the parent company's pipeline. However, as part of a strategic realignment to focus on the commercialization of its lead photodynamic therapy products, Biofrontera AG eventually divested or wound down its discovery operations.

Therapeutic areas: ImmunologyDermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Biofrontera Discovery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biofrontera Discovery.

Explore the full profile